{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T23:42:05Z","timestamp":1759534925779,"version":"build-2065373602"},"reference-count":68,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2007,10,1]],"date-time":"2007-10-01T00:00:00Z","timestamp":1191196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,10,1]],"date-time":"2007-10-01T00:00:00Z","timestamp":1191196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology"],"published-print":{"date-parts":[[2007,10]]},"DOI":"10.1016\/j.tox.2007.07.018","type":"journal-article","created":{"date-parts":[[2007,8,2]],"date-time":"2007-08-02T07:27:04Z","timestamp":1186039624000},"page":"70-85","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Hepatic nitroreduction, toxicity and toxicokinetics of the anti-tumour prodrug CB 1954 in mouse and rat"],"prefix":"10.1016","volume":"240","author":[{"given":"Magdalene Huen Yin","family":"Tang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nuala A.","family":"Helsby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael A.","family":"Goldthorpe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kirsty M.","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saad","family":"Al-Ali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malcolm D.","family":"Tingle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.tox.2007.07.018_bib1","first-page":"1131","article-title":"Ultrastructural changes in rat livers perfused in vitro and in vivo with a high dose of methotrexate","volume":"20","author":"Al-Ali","year":"2005","journal-title":"Histol. Histopathol."},{"key":"10.1016\/j.tox.2007.07.018_bib2","doi-asserted-by":"crossref","first-page":"219","DOI":"10.2174\/138920006776359284","article-title":"Reactive intermediates and the pathogenesis of adverse drug reactions: the toxicology perspective","volume":"7","author":"Amacher","year":"2006","journal-title":"Curr. Drug. Metab."},{"key":"10.1016\/j.tox.2007.07.018_bib3","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1016\/0006-2952(92)90671-5","article-title":"The bioactivation of 5-(aziridin-1-yl)-2,4-dinitrobenzamide (CB 1954). I. Purification and properties of a nitroreductase enzyme from Escherichia coli\u2014a potential enzyme for antibody-directed enzyme prodrug therapy (ADEPT)","volume":"44","author":"Anlezark","year":"1992","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.tox.2007.07.018_bib4","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/0006-2952(95)00187-5","article-title":"Bioactivation of dinitrobenzamide mustards by an E. coli B nitroreductase","volume":"50","author":"Anlezark","year":"1995","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.tox.2007.07.018_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.taap.2004.04.006","article-title":"Distribution of nitroreductive activity toward nilutamide in rat","volume":"201","author":"Ask","year":"2004","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.tox.2007.07.018_bib6","first-page":"383","article-title":"Histopathologic changes in liver and renal tissues induced by Ochratoxin A and melatonin in rats","volume":"22","author":"Aydin","year":"2003","journal-title":"Hum. Exp. Toxicol."},{"key":"10.1016\/j.tox.2007.07.018_bib7","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/0024-3205(78)90280-1","article-title":"Immunohistochemical localization of NADPH-cytochrome c reductase in rat liver","volume":"22","author":"Baron","year":"1978","journal-title":"Life Sci."},{"key":"10.1016\/j.tox.2007.07.018_bib8","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/S0022-3565(25)24707-3","article-title":"Generation of free radicals during the reductive metabolism of the nitroaromatic compound, nilutamide","volume":"257","author":"Berson","year":"1991","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.tox.2007.07.018_bib9","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.clpt.2006.02.012","article-title":"Drug-induced liver injury: Hy's rule revisited","volume":"79","author":"Bj\u00f6rnsson","year":"2006","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.tox.2007.07.018_bib10","doi-asserted-by":"crossref","first-page":"633","DOI":"10.2165\/00002018-200225090-00003","article-title":"Mechanisms of NSAID-induced hepatotoxicity: focus on nimesulide","volume":"25","author":"Boelsterli","year":"2002","journal-title":"Drug Saf."},{"key":"10.1016\/j.tox.2007.07.018_bib11","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/0006-2952(91)90190-G","article-title":"The differences in kinetics of rat and human DT diaphorase result in a differential sensitivity of derived cell lines to CB 1954 (5-(aziridin-1-yl)-2,4-dinitrobenzamide)","volume":"41","author":"Boland","year":"1991","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.tox.2007.07.018_bib12","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1016\/0959-8049(95)00436-X","article-title":"Expression of the bacterial nitroreductase enzyme in mammalian cells renders them selectively sensitive to killing by the prodrug CB 1954","volume":"31A","author":"Bridgewater","year":"1995","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.tox.2007.07.018_bib13","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1124\/jpet.300.2.460","article-title":"Underlying endotoxemia augments toxic responses to chlorpromazine: is there a relationship to drug idiosyncrasy?","volume":"300","author":"Buchweitz","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.tox.2007.07.018_bib14","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1074\/jbc.272.3.1437","article-title":"Molecular basis of the catalytic differences among DT-diaphorase of human, rat and mouse","volume":"272","author":"Chen","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tox.2007.07.018_bib15","first-page":"2662","article-title":"Virus-directed, enzyme prodrug therapy with nitroimidazole reductase: a phase I and pharmacokinetic study of its prodrug, CB 1954","volume":"7","author":"Chung-Faye","year":"2001","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.tox.2007.07.018_bib16","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/0041-008X(70)90147-X","article-title":"Toxicity of the selective antitumor agent 5-aziridino-2,4-dinitrobenzamide in the rat","volume":"17","author":"Cobb","year":"1970","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.tox.2007.07.018_bib17","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/0165-022X(86)90102-8","article-title":"Methodologies for the application of monobromobimane to the simultaneous analysis of soluble and protein thiol components of biological systems","volume":"13","author":"Cotgreave","year":"1986","journal-title":"J. Biochem. Biophys. Methods"},{"key":"10.1016\/j.tox.2007.07.018_bib18","first-page":"4256","article-title":"Hepatobiliary damage and changes in hepatic gene expression caused by the antitumor drug ecteinascidin-743 (ET-743) in the female rat","volume":"62","author":"Donald","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.tox.2007.07.018_bib19","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1002\/ijc.20356","article-title":"Dietary agent indole-3-carbinol protects female rats against the hepatotoxicity of the antitumor drug ET-743 (trabectidin) without compromising efficacy in a rat mammary carcinoma","volume":"111","author":"Donald","year":"2004","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.tox.2007.07.018_bib20","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0022-3565(25)10360-1","article-title":"Mechanism for the hepatotoxicity of the antiandrogen, nilutamide. Evidence suggesting that redox cycling of this nitroaromatic drug leads to oxidative stress in isolated hepatocytes","volume":"263","author":"Fau","year":"1992","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.tox.2007.07.018_bib21","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1021\/jm960794l","article-title":"Mustard prodrugs for activation by Escherichia coli nitroreductase in gene-directed enzyme prodrug therapy","volume":"40","author":"Friedlos","year":"1997","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.tox.2007.07.018_bib22","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/0272-0590(85)90061-2","article-title":"Effects of methapyrilene on rat hepatic xenobiotic metabolizing enzymes and liver morphology","volume":"5","author":"Graichen","year":"1985","journal-title":"Fundam. Appl. Toxicol."},{"key":"10.1016\/j.tox.2007.07.018_bib23","series-title":"Elsevier Science B.V.","article-title":"Histopathology of preclinical toxicity studies: interpretation and relevance in drug safety evaluation","author":"Greaves","year":"2000"},{"key":"10.1016\/j.tox.2007.07.018_bib24","first-page":"229","article-title":"Sensitization of colorectal and pancreatic cancer cell lines to the prodrug 5-(aziridin-1-yl)-2,4-dinitrobenzamide (CB 1954) by retroviral transduction and expression of the E. coli nitroreductase gene","volume":"4","author":"Green","year":"1997","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.tox.2007.07.018_bib25","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1021\/tx025662b","article-title":"Effect of nitroreduction on the alkylating reactivity and cytotoxicity of the 2,4-dinitrobenzamide-5-aziridine CB 1954 and the corresponding nitrogen mustard SN 23862: distinct mechanisms of bioreductive activation","volume":"16","author":"Helsby","year":"2003","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.tox.2007.07.018_bib26","doi-asserted-by":"crossref","first-page":"3295","DOI":"10.1021\/jm0498699","article-title":"Aziridinyldinitrobenzamides: synthesis and structure-activity relationships for activation by E. coli nitroreductase","volume":"47","author":"Helsby","year":"2004","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.tox.2007.07.018_bib27","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1038\/sj.bjc.6601612","article-title":"2-Amino metabolites are key mediators of CB 1954 and SN 23862 bystander effects in nitroreductase GDEPT","volume":"90","author":"Helsby","year":"2004","journal-title":"Br. J. Cancer"},{"issue":"Suppl. 6","key":"10.1016\/j.tox.2007.07.018_bib28","first-page":"1173","article-title":"Species differences in the metabolism of benzene","volume":"104","author":"Henderson","year":"1996","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.tox.2007.07.018_bib29","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0300-483X(96)03422-1","article-title":"Metabolism of 1,3-butadiene: species differences","volume":"113","author":"Henderson","year":"1996","journal-title":"Toxicology"},{"key":"10.1016\/j.tox.2007.07.018_bib30","doi-asserted-by":"crossref","first-page":"4572","DOI":"10.1200\/jco.2004.22.90140.4572","article-title":"A clinical trial of virus-encoded enzyme prodrug therapy (VDEPT) using adenovirus encoded nitroreductase (ntr) and CB 1954 in patients with localized prostate cancer (PCa)","volume":"22","author":"James","year":"2004","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.tox.2007.07.018_bib31","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1016\/0006-2952(76)90451-2","article-title":"The metabolism of the anti-tumour agent 5-(1-aziridinyl)-2,4-dinitrobenzamide (CB 1954)","volume":"25","author":"Jarman","year":"1976","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.tox.2007.07.018_bib32","doi-asserted-by":"crossref","first-page":"4333","DOI":"10.1021\/jm051246n","article-title":"Design, synthesis, and biological evaluation of cyclic and acyclic nitrobenzylphosphoramide mustards for E. coli nitroreductase activation","volume":"49","author":"Jiang","year":"2006","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.tox.2007.07.018_bib33","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/nrd1750","article-title":"Idiosyncratic drug hepatotoxicity","volume":"4","author":"Kaplowitz","year":"2005","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.tox.2007.07.018_bib34","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.ejca.2003.11.028","article-title":"Of mice and men: values and liabilities of the athymic nude mouse model in anticancer drug development","volume":"40","author":"Kelland","year":"2004","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.tox.2007.07.018_bib35","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s002800000165","article-title":"Pharmacokinetics and metabolism of the nitrogen mustard bioreductive drug 5-[N,N-bis(2-chloroethyl)amino]-2,4-dinitrobenzamide (SN 23862) and the corresponding aziridine (CB 1954) in KHT tumour-bearing mice","volume":"46","author":"Kestell","year":"2000","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.tox.2007.07.018_bib36","doi-asserted-by":"crossref","first-page":"4671","DOI":"10.1016\/0006-2952(88)90336-X","article-title":"The nitroreductase enzyme in Walker cells that activates 5-(aziridin-1-yl)-2,4-dinitrobenzamide (CB 1954) to 5-(aziridin-1-yl)-4-hydroxylamino-2-nitrobenzamide is a form of NAD(P)H dehydrogenase (quinone) (EC 1.6.99.2)","volume":"37","author":"Knox","year":"1988","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.tox.2007.07.018_bib37","doi-asserted-by":"crossref","first-page":"4661","DOI":"10.1016\/0006-2952(88)90335-8","article-title":"A new cytotoxic, DNA interstrand cross-linking agent, 5-(aziridin-1-yl)-4-hydroxylamino-2-nitrobenzamide, is formed from 5-(aziridin-1-yl)-2,4-dinitrobenzamide (CB 1954) by a nitroreductase enzyme in Walker carcinoma cells","volume":"37","author":"Knox","year":"1988","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.tox.2007.07.018_bib38","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1016\/0006-2952(91)90503-W","article-title":"Bioactivation of CB 1954: reaction of the active 4-hydroxylamino derivative with thioesters to form the ultimate DNA\u2013DNA interstrand cross-linking species","volume":"42","author":"Knox","year":"1991","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.tox.2007.07.018_bib39","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/BF01612895","article-title":"Anomalies in the hormonal status of athymic nude mice","volume":"116","author":"Kopf-Maier","year":"1990","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.tox.2007.07.018_bib40","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1093\/carcin\/2.6.473","article-title":"Alpha-naphthylisothiocyanate-induced alterations in hepatic drug metabolizing enzymes and liver morphology: implications concerning anticarcinogenesis","volume":"2","author":"Leonard","year":"1981","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.tox.2007.07.018_bib41","first-page":"262","article-title":"Serum gamma glutamyl transferase as a specific indicator of bile duct lesions in the rat liver","volume":"116","author":"Leonard","year":"1984","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.tox.2007.07.018_bib42","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1016\/0024-3205(78)90624-0","article-title":"In vitro drug metabolism in male and female athymic, nude mice","volume":"22","author":"Litterst","year":"1978","journal-title":"Life Sci."},{"key":"10.1016\/j.tox.2007.07.018_bib43","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1080\/00498250412331285463","article-title":"Metabolism of human cytochrome P450 marker substrates in mouse: a strain and gender comparison","volume":"34","author":"Lofgren","year":"2004","journal-title":"Xenobiotica"},{"key":"10.1016\/j.tox.2007.07.018_bib44","first-page":"189","article-title":"Immunohistochemical localization and quantitation of NADPH-cytochrome P-450 reductase in human liver","volume":"32","author":"McManus","year":"1987","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.tox.2007.07.018_bib45","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1124\/mol.52.1.46","article-title":"Thyroid regulation of NADPH:cytochrome P450 oxidoreductase: identification of a thyroid-responsive element in the 5\u2032-flank of the oxidoreductase gene","volume":"52","author":"O\u2019Leary","year":"1997","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.tox.2007.07.018_bib46","doi-asserted-by":"crossref","first-page":"3214","DOI":"10.1021\/jm00095a018","article-title":"Hypoxia-selective antitumor agents 5. Synthesis of water-soluble nitroaniline mustards with selective cytotoxicity for hypoxic mammalian cells","volume":"35","author":"Palmer","year":"1992","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.tox.2007.07.018_bib47","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1021\/jm00040a009","article-title":"Hypoxia-selective antitumor agents. 9. Structure-activity relationships for hypoxia-selective cytotoxicity among analogues of 5-[N,N-bis(2-chloroethyl)amino]-2,4-dinitrobenzamide","volume":"37","author":"Palmer","year":"1994","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.tox.2007.07.018_bib48","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1021\/jm960057p","article-title":"Hypoxia-selective antitumor agents. 14. Synthesis and hypoxic cell cytotoxicity of regioisomers of the hypoxia-selective cytotoxin 5-[N,N-bis(2-chloroethyl)amino]-2,4-dinitrobenzamide","volume":"39","author":"Palmer","year":"1996","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.tox.2007.07.018_bib49","doi-asserted-by":"crossref","first-page":"3157","DOI":"10.1200\/jco.2005.23.16_suppl.3157","article-title":"Virus-directed enzyme prodrug therapy (VDEPT): a clinical trial of adenovirus-delivered nitroreductase (NTR) in combination with CB 1954 in patients with primary or secondary liver cancer","volume":"23","author":"Palmer","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.tox.2007.07.018_bib50","doi-asserted-by":"crossref","first-page":"3091","DOI":"10.1200\/jco.2005.23.16_suppl.3091","article-title":"Suicide gene therapy using adenovirus encoded nitroreductase and CB 1954 in patients with locally relapsed prostate cancer","volume":"23","author":"Patel","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.tox.2007.07.018_bib51","doi-asserted-by":"crossref","first-page":"3922","DOI":"10.1158\/1078-0432.CCR-07-0478","article-title":"Mechanism of action and preclinical antitumor activity of the novel hypoxia-activated DNA cross-linking agent PR-104","volume":"13","author":"Patterson","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.tox.2007.07.018_bib52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/jpet.102.041624","article-title":"Inflammation and drug idiosyncrasy\u2014is there a connection?","volume":"307","author":"Roth","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.tox.2007.07.018_bib53","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.cbi.2006.02.007","article-title":"On the species\u2013specific biotransformation of dibenzo[a,l]pyrene","volume":"161","author":"Schober","year":"2006","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.tox.2007.07.018_bib54","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1111\/j.1440-1681.2004.04085.x","article-title":"Nitroreductase: a prodrug-activating enzyme for cancer gene therapy","volume":"31","author":"Searle","year":"2004","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.tox.2007.07.018_bib55","first-page":"357","article-title":"Nitro reduction as an electronic switch for bioreductive drug activation","volume":"9","author":"Siim","year":"1997","journal-title":"Oncol. Res."},{"key":"10.1016\/j.tox.2007.07.018_bib56","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1023\/A:1011950218824","article-title":"Electrochemical generation and interaction study of the nitro radical anion from nimesulide","volume":"16","author":"Squella","year":"1999","journal-title":"Pharm. Res."},{"key":"10.1016\/j.tox.2007.07.018_bib57","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.tox.2005.07.021","article-title":"Aerobic 2- and 4-nitroreduction of CB 1954 by human liver","volume":"216","author":"Tang","year":"2005","journal-title":"Toxicology"},{"key":"10.1016\/j.tox.2007.07.018_bib58","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.freeradbiomed.2005.05.013","article-title":"Mitochondrial permeability transition as a source of superoxide anion induced by the nitroaromatic drug nimesulide in vitro","volume":"39","author":"Tay","year":"2005","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.tox.2007.07.018_bib59","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1128\/AAC.24.1.89","article-title":"Comparative metabolism of chloramphenicol in germfree and conventional rats","volume":"24","author":"Wal","year":"1983","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.tox.2007.07.018_bib60","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1080\/10408440590935620","article-title":"Role of metabolism in drug-induced idiosyncratic hepatotoxicity","volume":"35","author":"Walgren","year":"2005","journal-title":"Crit. Rev. Toxicol."},{"key":"10.1016\/j.tox.2007.07.018_bib61","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.fct.2005.08.010","article-title":"Inter-species comparison of liver and small intestinal microsomal metabolism of fluoranthene","volume":"44","author":"Walker","year":"2006","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.tox.2007.07.018_bib62","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/0360-3016(89)90900-0","article-title":"Molecular enzymology of the reductive bioactivation of hypoxic cell cytotoxins","volume":"16","author":"Walton","year":"1989","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.tox.2007.07.018_bib63","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/0360-3016(92)90495-4","article-title":"The role of human and rodent DT-diaphorase in the reductive metabolism of hypoxic cell cytotoxins","volume":"22","author":"Walton","year":"1992","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.tox.2007.07.018_bib64","first-page":"1425","article-title":"Quantitation of bystander effects in nitroreductase suicide gene therapy using three-dimensional cell cultures","volume":"62","author":"Wilson","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.tox.2007.07.018_bib65","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1667\/RR0807.1","article-title":"Bystander effects of bioreductive drugs: potential for exploiting pathological tumor hypoxia with dinitrobenzamide mustards","volume":"167","author":"Wilson","year":"2007","journal-title":"Radiat. Res."},{"key":"10.1016\/j.tox.2007.07.018_bib66","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/BF00255279","article-title":"CB 1954 revisited. II. Toxicity and anti-tumour activity","volume":"16","author":"Workman","year":"1986","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.tox.2007.07.018_bib67","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF00255278","article-title":"CB 1954 revisited. I. Disposition kinetics and metabolism","volume":"16","author":"Workman","year":"1986","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.tox.2007.07.018_bib68","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1124\/jpet.104.073353","article-title":"Transgenic mice with a hypomorphic NADPH-cytochrome P450 reductase gene: effects on development, reproduction, and microsomal cytochrome P450","volume":"312","author":"Wu","year":"2005","journal-title":"J. Pharmacol. Exp. Ther."}],"container-title":["Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300483X07004842?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300483X07004842?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T22:58:32Z","timestamp":1759532312000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0300483X07004842"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,10]]},"references-count":68,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2007,10]]}},"alternative-id":["S0300483X07004842"],"URL":"https:\/\/doi.org\/10.1016\/j.tox.2007.07.018","relation":{},"ISSN":["0300-483X"],"issn-type":[{"type":"print","value":"0300-483X"}],"subject":[],"published":{"date-parts":[[2007,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hepatic nitroreduction, toxicity and toxicokinetics of the anti-tumour prodrug CB 1954 in mouse and rat","name":"articletitle","label":"Article Title"},{"value":"Toxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tox.2007.07.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}